https://www.selleckchem.com/products/en460.html
uctural failures that are leading to unacceptable and substandard maternal and infant outcomes.The regulatory community is transitioning to the use of nonanimal methods for dermal sensitization assessments; however, some in vitro assays have limitations in their domain of applicability depending on the properties of chemicals being tested. This study explored the utility of epidermal sensitization assay (EpiSensA) to evaluate the sensitization potential of complex and/or "difficult to test" chemicals. Assay performance was evaluated by te
Like
Comment
Share
